281 related articles for article (PubMed ID: 38090567)
1. Cancer stem cell-immune cell crosstalk in breast tumor microenvironment: a determinant of therapeutic facet.
Guha A; Goswami KK; Sultana J; Ganguly N; Choudhury PR; Chakravarti M; Bhuniya A; Sarkar A; Bera S; Dhar S; Das J; Das T; Baral R; Bose A; Banerjee S
Front Immunol; 2023; 14():1245421. PubMed ID: 38090567
[TBL] [Abstract][Full Text] [Related]
2. Role, molecular mechanism and the potential target of breast cancer stem cells in breast cancer development.
Zhang T; Zhou H; Wang K; Wang X; Wang M; Zhao W; Xi X; Li Y; Cai M; Zhao W; Xu Y; Shao R
Biomed Pharmacother; 2022 Mar; 147():112616. PubMed ID: 35008001
[TBL] [Abstract][Full Text] [Related]
3. Role of cancer stem cell ecosystem on breast cancer metastasis and related mouse models.
Peng X; Dong H; Zhang L; Liu S
Zool Res; 2024 May; 45(3):506-517. PubMed ID: 38682432
[TBL] [Abstract][Full Text] [Related]
4. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
[TBL] [Abstract][Full Text] [Related]
5. Unraveling the Potential of miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis.
Nogueras Pérez R; Heredia-Nicolás N; de Lara-Peña L; López de Andrés J; Marchal JA; Jiménez G; Griñán-Lisón C
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958993
[TBL] [Abstract][Full Text] [Related]
6. LINC00261/microRNA-550a-3p/SDPR axis affects the biological characteristics of breast cancer stem cells.
Li Y; Wu C
IUBMB Life; 2021 Jan; 73(1):188-201. PubMed ID: 33274565
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
[TBL] [Abstract][Full Text] [Related]
8. RUNX1 and RUNX2 transcription factors function in opposing roles to regulate breast cancer stem cells.
Fritz AJ; Hong D; Boyd J; Kost J; Finstaad KH; Fitzgerald MP; Hanna S; Abuarqoub AH; Malik M; Bushweller J; Tye C; Ghule P; Gordon J; Frietze S; Zaidi SK; Lian JB; Stein JL; Stein GS
J Cell Physiol; 2020 Oct; 235(10):7261-7272. PubMed ID: 32180230
[TBL] [Abstract][Full Text] [Related]
9. Breast Cancer Stem Cells-derived Extracellular Vesicles Affect PPARG Expression by Delivering MicroRNA-197 in Breast Cancer Cells.
Li L; Xiong Y; Wang N; Zhu M; Gu Y
Clin Breast Cancer; 2022 Jul; 22(5):478-490. PubMed ID: 35279406
[TBL] [Abstract][Full Text] [Related]
10. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
[TBL] [Abstract][Full Text] [Related]
11. Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment.
Pires BR; DE Amorim ÍS; Souza LD; Rodrigues JA; Mencalha AL
Anticancer Res; 2016 Nov; 36(11):5681-5691. PubMed ID: 27793889
[TBL] [Abstract][Full Text] [Related]
12. Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.
Piggott L; Omidvar N; Martí Pérez S; French R; Eberl M; Clarkson RW
Breast Cancer Res; 2011 Sep; 13(5):R88. PubMed ID: 21914219
[TBL] [Abstract][Full Text] [Related]
13. Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.
Giordano C; Chemi F; Panza S; Barone I; Bonofiglio D; Lanzino M; Cordella A; Campana A; Hashim A; Rizza P; Leggio A; Győrffy B; Simões BM; Clarke RB; Weisz A; Catalano S; Andò S
Oncotarget; 2016 Jan; 7(2):1262-75. PubMed ID: 26556856
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells.
Tong M; Deng Z; Yang M; Xu C; Zhang X; Zhang Q; Liao Y; Deng X; Lv D; Zhang X; Zhang Y; Li P; Song L; Wang B; Al-Dherasi A; Li Z; Liu Q
Cancer Commun (Lond); 2018 Sep; 38(1):56. PubMed ID: 30231942
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer stem cells phenotype and plasma cell-predominant breast cancer independently indicate poor survival.
Wei H; Fu P; Yao M; Chen Y; Du L
Pathol Res Pract; 2016 Apr; 212(4):294-301. PubMed ID: 26857534
[TBL] [Abstract][Full Text] [Related]
16. Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram.
Sun T; Yang W; Toprani SM; Guo W; He L; DeLeo AB; Ferrone S; Zhang G; Wang E; Lin Z; Hu P; Wang X
Cell Commun Signal; 2020 Mar; 18(1):36. PubMed ID: 32138738
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity and Plasticity of Breast Cancer Stem Cells.
Sousa B; Ribeiro AS; Paredes J
Adv Exp Med Biol; 2019; 1139():83-103. PubMed ID: 31134496
[TBL] [Abstract][Full Text] [Related]
18. SURVIVIN as a marker for quiescent-breast cancer stem cells-An intermediate, adherent, pre-requisite phase of breast cancer metastasis.
Siddharth S; Das S; Nayak A; Kundu CN
Clin Exp Metastasis; 2016 Oct; 33(7):661-75. PubMed ID: 27411340
[TBL] [Abstract][Full Text] [Related]
19. Targeting Breast Cancer Stem Cells.
Zhang L; Chen W; Liu S; Chen C
Int J Biol Sci; 2023; 19(2):552-570. PubMed ID: 36632469
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer stem cells: Multiple capacities in tumor metastasis.
Geng SQ; Alexandrou AT; Li JJ
Cancer Lett; 2014 Jul; 349(1):1-7. PubMed ID: 24727284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
